Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAPB Trial: Exparel vs Bupivacaine vs Placebo
NCT03730402Phase 4Terminated
- Sponsor
- Santa Barbara Cottage Hospital
- Start
- Feb 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Santa Barbara Cottage Hospital. Primary endpoint: Narcotic Usage at 24 hours. Started Feb 2019; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03730402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03730402.